Merck and Moderna plot cancer vaccine expansion, China’s boom reshapes global venture investing, and more biotech news Revolution Medicines Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. We’re leaving room for popcorn and intrigue tonight: The new A24 documentary, “You Can See Everything,” hits theaters today. I remember back at the American Chemical Society meeting in 2016, a skeptical pathologist told me in advance of a purported Theranos data unveil: STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in View All Plans To read the rest of this story subscribe to STAT+. Subscribe Meghana Keshavan covers biotech and contributes to The Readout newsletter. Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71.
STAT+: RevMed’s pancreatic cancer drug nears European approval
Full Article
Original Source
Read the full article at Statnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.